Neurol. praxi. 2014;15(5):258-260
Immunomodulatory properties of intravenous immunoglobulin
- MS Centrum Teplice, Neurologické oddělení KZ a.s. &ndash, Nemocnice Teplice o. z.
- Neurologická klinika 1. LF UK a VFN, Praha
Intravenous immunoglobulin is a biological product, manufactured from plasma of healthy donors. Its relative safety and complete immunomodulatory effects affect its consumption rising in inflammatory and autoimmune diseases, notably in neurology. This review article summarizes the current knowledge on the mechanisms of action of intravenous immunoglobulin with respect to different fragments of immunoglobulin molecules G.
Keywords: intravenous imunoglobulin, immunomodulation, autoimmune diseases
Published: November 18, 2014 Show citation
References
- Alder LB, Morgan LA, Spickett GP. Contribution of stabilizing agents present in intravenous immunoglobulin preparations to modulation of mononuclear cell proliferation in vitro. Scand J Immunol 1996; 44: 585-591.
Go to original source... 
Go to PubMed... - Aktas O, Waiczies S, Grieger U, Wendling U, Zschenderlein R, Zipp F. Polyspecific immunoglobulins (IVIg) suppress proliferation of human (auto) antigen-specific T cells without inducing apoptosis. J Neuroimmunol 2001; 114: 160-167. Go to original source... Go to PubMed...
- Bayry J, Thirion M, Misra N, Thorenoor N, Delignat S, Lacroix-Desmazes S, Bellon B, Kaveri S, Kazatchkine MD. Mechanism of action of intravenous immunoglobuulin i autoimmune and inflammatory disease. Neurol Sxci 2003; 24: S217-S221. Go to original source... Go to PubMed...
- Bruhns P, Samuelsson A, Pollard JW, Ravetch JV. Colony-stimulating factor-1-dependent macrophages are responsible for IVIG protection in antibody-induced autoimmune disease. Immunity 2003; 18: 573-581. Go to original source... Go to PubMed...
- Buttmann M, Kaveri S, Hartung HP. Polyclonal immunoglobulin G for autoimmune demyelinating nervous system disorders. Trends Pharmacol Sci. 2013; 34(8): 445-457. Go to original source... Go to PubMed...
- Imbach P, Barandun S, d'Apuzzo V, Baumgartner C, Hirt A, Morell A, Rossi E, Schöni M, Vest M, Wagner HP. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura inchildhood. Lancet 1981; 1: 1228-1231. Go to original source... Go to PubMed...
- Jolles S, Sewell WA, Misbah SA.Clinical uses of intravenous immunoglobulin. Clin Exp Immunol. 2005; 142(1): 1-11. Go to original source... Go to PubMed...
- Sé?té JF, Goutsmedt C, Youinou P, Pers JO, Hillion S. Intravenous immunoglobulin induces a functional silencing program similar to anergy in human B cells. J Allergy Clin Immunol. 2014; 133(1): 181-188. Go to original source... Go to PubMed...
- Spahn JD, Leung DY, Chan MT, Szefler SJ, Gelfand EW. Mechanisms of glucocorticoid reduction in asthmatic subjects treated with intravenous immunoglobulin. J Allergy Clin Immunol 1999; 103: 421-426. Go to original source... Go to PubMed...
- Stangel M, Bernard D. Polyclonal IgM influence oligodendrocyte precursor cells in mixed glial cell cultures: implications for remyelination.J Neuroimmunol. 2003; 138(1-2): 25-30. Go to original source... Go to PubMed...
- ©palek P. Intravenózny imunoglobulin v liečbě autoimunitných neurologických ochorení. Neurol praxi 2011; 12(6): 398-402.
- Takei S, Arora YK, Walker SM. Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens. J Clin Invest 1993; 91: 602-607. Go to original source... Go to PubMed...
- Vassilev TL, Kazatchkine MD, Duong Van Huyen JP, Mekrache M, Bonnin E, Mani JC, Lecroubier C, Korinth D, Baruch D, Schriever F, Kaveri SV. Inhibition of cell adhesion by antibodies to Arg-Gly-Asp (RGD) in normal immunoglobulin for therapeutic use (intravenous immunoglobulin, IVIg). Blood 1999; 93: 3624-363. Go to original source...